Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132767 · ClinicalTrials.gov registry record · Phase 3
Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation
A Phase 3 study of Postoperative Atrial Fibrillation, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 3
- Development phase
- 523
- Enrollment target
- 20
- Study locations
NCT02132767 is a Phase 3 study of Postoperative Atrial Fibrillation that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 523 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT02132767, a Phase 3 study of Postoperative Atrial Fibrillation, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 523 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to compare the therapeutic strategies of rate control versus rhythm control in cardiac surgery patients who develop in-hospital postoperative atrial fibrillation or atrial flutter (AF). In patients who develop AF during hospitalization after cardiac surgery, the hypothesis is that a strategy of rhythm control will reduce days in hospital within 60 days of the occurrence of AF compared to a strategy of rate control.
Conditions Studied
Interventions
- DRUG Amiodarone
- PROCEDURE DC-cardioversion
- DRUG Rate Control
Study Locations (20)
New York
- Icahn School of Medicine at Mount Sinai - New York
- Columbia University Medical Center - New York
- Montefiore Einstein Heart Center - The Bronx
Maryland
- University of Maryland - Baltimore
- NIH Heart Center at Suburban Hospital - Bethesda
North Carolina
- Mission Hospital - Asheville
- Duke University - Durham
Ohio
- Cleveland Clinic Foundation - Cleveland
- The Ohio State University Medical Center - Columbus
Texas
- Baylor College of Medicine - Houston
- Baylor Research Institute - Plano
California
- University of Southern California - Los Angeles
Georgia
- Emory University - Atlanta
Michigan
- University of Michigan Health Services - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 523 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02132767
The ClinicalTrials.gov registry entry for NCT02132767 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 523 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Atrial Fibrillation appearing as the primary indexed condition, and to 3 interventions - of which Amiodarone is the first listed.
NCT02132767 reports 20 study locations spanning 14 distinct geographic areas - top geographies include New York, Maryland, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02132767 about?
NCT02132767 is a clinical study titled "Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation". The purpose of this study is to compare the therapeutic strategies of rate control versus rhythm control in cardiac surgery patients who develop in-hospital postoperative atrial fibrillation or atrial flutter (AF). In patients who develop AF during hospitalization after cardiac surgery, the hypothes...
What is the current status of trial NCT02132767?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 523 participants. The study started on 2014-05. Estimated completion is 2015-09.
What conditions does trial NCT02132767 study?
This clinical trial studies the following conditions: Postoperative Atrial Fibrillation.
What interventions are being tested in trial NCT02132767?
The interventions under investigation include: Amiodarone (DRUG), DC-cardioversion (PROCEDURE), Rate Control (DRUG).
Who is sponsoring clinical trial NCT02132767?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02132767 being conducted?
This trial has 20 study locations across California, Georgia, Maryland, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.